BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, Ní Choileáin O, Clarke J, O'Connor E, Hogan G, Ryan D, Sulaiman I, Gunaratnam C, Branagan P, O'Brien ME, Morgan RK, Costello RW, Hurley K, Walsh S, de Barra E, McNally C, McConkey S, Boland F, Galvin S, Kiernan F, O'Rourke J, Dwyer R, Power M, Geoghegan P, Larkin C, O'Leary RA, Freeman J, Gaffney A, Marsh B, Curley GF, McElvaney NG. Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med 2020;202:812-21. [PMID: 32584597 DOI: 10.1164/rccm.202005-1583OC] [Cited by in Crossref: 297] [Cited by in F6Publishing: 315] [Article Influence: 148.5] [Reference Citation Analysis]
Number Citing Articles
1 García-Hidalgo MC, González J, Benítez ID, Carmona P, Santisteve S, Pérez-Pons M, Moncusí-Moix A, Gort-Paniello C, Rodríguez-Jara F, Molinero M, Belmonte T, Torres G, Labarca G, Nova-Lamperti E, Caballero J, Bermejo-Martin JF, Ceccato A, Fernández-Barat L, Ferrer R, Garcia-Gasulla D, Menéndez R, Motos A, Peñuelas O, Riera J, Torres A, Barbé F, de Gonzalo-Calvo D; CIBERESUCICOVID Project (COV20/00110, ISCIII). Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS. Emerg Microbes Infect 2022;11:1537-49. [PMID: 35603455 DOI: 10.1080/22221751.2022.2081615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Akbasheva OE, Spirina LV, Dyakov DA, Masunova NV. Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection. Biochem Moscow Suppl Ser B 2022;16:271-291. [DOI: 10.1134/s1990750822040035] [Reference Citation Analysis]
3 Yu Z, Li X, Zhao J, Sun S. Identification of hospitalized mortality of patients with COVID-19 by machine learning models based on blood inflammatory cytokines. Front Public Health 2022;10. [DOI: 10.3389/fpubh.2022.1001340] [Reference Citation Analysis]
4 George PM, Reed A, Desai SR, Devaraj A, Faiez TS, Laverty S, Kanwal A, Esneau C, Liu MK, Kamal F, Man WD, Kaul S, Singh S, Lamb G, Faizi FK, Schuliga M, Read J, Burgoyne T, Pinto AL, Micallef J, Bauwens E, Candiracci J, Bougoussa M, Herzog M, Raman L, Ahmetaj-shala B, Turville S, Aggarwal A, Farne HA, Dalla Pria A, Aswani AD, Patella F, Borek WE, Mitchell JA, Bartlett NW, Dokal A, Xu X, Kelleher P, Shah A, Singanayagam A. A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae. Sci Transl Med 2022;14. [DOI: 10.1126/scitranslmed.abo5795] [Reference Citation Analysis]
5 Moura AEF, Oliveira DN, Torres DM, Tavares-júnior JWL, Nóbrega PR, Braga-neto P, Sobreira-neto MA. Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study. BMC Neurol 2022;22:417. [DOI: 10.1186/s12883-022-02940-7] [Reference Citation Analysis]
6 Zhu W, Chen P, Wang K, Xing X. The effect of transpyloric enteral nutrition on inflammatory response and prognosis for patients with Corona Virus Disease-19 in intensive care unit: A STROBE compliant study. Medicine 2022;101:e31294. [DOI: 10.1097/md.0000000000031294] [Reference Citation Analysis]
7 Delhommeau G, Buetti N, Neuville M, Siami S, Cohen Y, Laurent V, Mourvillier B, Reignier J, Goldgran-toledano D, Schwebel C, Ruckly S, de Montmollin E, Souweine B, Timsit J, Dupuis C. Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study. Biomedicines 2022;10:2646. [DOI: 10.3390/biomedicines10102646] [Reference Citation Analysis]
8 Fagherazzi G, Zhang L, Elbéji A, Higa E, Despotovic V, Ollert M, Aguayo GA, Nazarov PV, Fischer A. A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: Findings from the prospective Predi-COVID cohort study. PLOS Digit Health 2022;1:e0000112. [DOI: 10.1371/journal.pdig.0000112] [Reference Citation Analysis]
9 Butusov AM, Krusko OV, Potapov PK, Derevyankin DS, Zagranichnov VD, Malyshkin SS, Zhurbin EA. Polymorphisms of leukocyte genes human and congenital antigen immunity associated with different the severity of the course of the new coronavirus infections. Bulletin of the Russian Military Medical Academy 2022;24:547-556. [DOI: 10.17816/brmma108133] [Reference Citation Analysis]
10 Abuhasira R, Grossman A. Glucose variability is a marker for COVID-19 severity and mortality. Archives of Endocrinology and Metabolism 2022. [DOI: 10.20945/2359-3997000000527] [Reference Citation Analysis]
11 Žarković N, Łuczaj W, Jarocka-karpowicz I, Orehovec B, Baršić B, Tarle M, Kmet M, Lukšić I, Biernacki M, Skrzydlewska E. Diversified Effects of COVID-19 as a Consequence of the Differential Metabolism of Phospholipids and Lipid Peroxidation Evaluated in the Plasma of Survivors and Deceased Patients upon Admission to the Hospital. IJMS 2022;23:11810. [DOI: 10.3390/ijms231911810] [Reference Citation Analysis]
12 Molina FJ, Botero LE, Isaza JP, Cano LE, López L, Hoyos LM, Correa E, Torres A. Cytokine levels as predictors of mortality in critically ill patients with severe COVID-19 pneumonia: Case-control study nested within a cohort in Colombia. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1005636] [Reference Citation Analysis]
13 Leung ON, Chiu NK, Wong SY, Cuijpers P, Alonso J, Chan PK, Lui G, Wong E, Bruffaerts R, Yip BH, Mortier P, Vilagut G, Kwok D, Lam LC, Kessler RC, Mak AD. Dimensional Structure of one-year Post-COVID-19 Neuropsychiatric and Somatic Sequelae and Association with Role Impairment.. [DOI: 10.21203/rs.3.rs-1923784/v1] [Reference Citation Analysis]
14 Xiang M, Wu X, Jing H, Liu L, Wang C, Wang Y, Novakovic VA, Shi J. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors. Front Immunol 2022;13:955654. [DOI: 10.3389/fimmu.2022.955654] [Reference Citation Analysis]
15 Alenazy MF, Aljohar HI, Alruwaili AR, Daghestani MH, Alonazi MA, Labban RS, El-ansary AK, Balto HA. Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications. Metabolites 2022;12:912. [DOI: 10.3390/metabo12100912] [Reference Citation Analysis]
16 Zhong H, Zhou Y, Mei S, Tang R, Feng J, He Z, Xu Q, Xing S. Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis. Front Public Health 2022;10:967829. [DOI: 10.3389/fpubh.2022.967829] [Reference Citation Analysis]
17 Lascano J, Oshins R, Eagan C, Wadood Z, Qiang X, Flagg T, Scindia Y, Mehrad B, Brantly M, Khodayari N. Correlation of alpha-1 antitrypsin levels and exosome associated neutrophil elastase endothelial injury in subjects with SARS-CoV2 infection. PLoS ONE 2022;17:e0274427. [DOI: 10.1371/journal.pone.0274427] [Reference Citation Analysis]
18 Zinellu A, Mangoni AA. A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality. Expert Rev Clin Immunol 2022;:1-16. [PMID: 36047369 DOI: 10.1080/1744666X.2022.2120472] [Reference Citation Analysis]
19 Keir HR, Long MB, Abo-leyah H, Giam YH, Vadiveloo T, Pembridge T, Hull RC, Delgado L, Band M, Mclaren-neil F, Adamson S, Lahnsteiner E, Gilmour A, Hughes C, New BJ, Connell D, Dowey R, Turton H, Richardson H, Cassidy D, Cooper J, Suntharalingam J, Diwakar L, Russell P, Underwood J, Hicks A, Dosanjh DP, Sage B, Dhasmana D, Spears M, Thompson AR, Brightling C, Smith A, Patel M, George J, Condliffe AM, Shoemark A, Maclennan G, Chalmers JD, Chalmers J, Abo-leyah H, New BJ, Almaden-boyle C, Connell D, Taylor J, Strachan J, Loftus H, Young L, Strachan A, Band M, Mclaren-neil F, Pilvinyte K, Adamson S, Lahnsteiner E, Rauchhaus P, Hogarth F, George J, Burns T, Coote E, Keiller M, Patel M, Smith A, Sage E, Cooper J, Miller D, Dosanjh D, Sutton B, Underwood J, Frayling S, Haynes M, Broad L, Jones L, Rahilly K, Oliver C, Evans T, Balan A, Davies R, Forde D, Nye C, Haboubi D, Hilton Z, Williams J, Mcqueen A, Spears M, Edmond I, Salutous D, Mcgenily L, Scott R, Henderson E, Collins A, Dhasmana D, Liu P, Morrow A, Couser M, Davey F, Hicks A, Wiffen L, Fox L, Abdelrahim M, Darbyshire A, Cowen E, Rowley M, Giles B, Yang Y, Brown T, Rupani H, Hawes E, Barnes D, Brogan F, Bungue-tuble R, Howe S, Turner C, Baryschpolec S, Longhurst B, Moon M, Watkins L, Baker-moffat M, Murray L, Harrington-davies Y, Burrows K, Minnis C, Wands M, Bamgboye A, Wong C, Brightling C, Diver S, Russell R, Mcauley H, Elneima O, Yousuf A, Mccourt P, Hargadon B, Parker S, Bourne M, Suntharalingam J, Hartley T, Masan V, Sturney S, Mackenzie R, Marchand C, Mason R, White K, Kirby A, Meda M, Diwakar L, Russell P, Finn J, Harris S, Muir C, Cook G, Staines N, Cook C, Thompson AR, Condliffe A, Hull R, Dowey R, Turton H, Collini P, Gabriel Z, Hardman S, Newell H, Middle J, Simpson P, Colton H, Barker J, Birchall K, Harrington K, Housley K, Lenagh R, Wilson J, Wesonga J, Whitham R, Bird S, Jackson Y, Mbuyisa A, Anderson S, Wilson A, Kibutu F, Walker S, Cawthron K, Macharia I, Smart L, Emery A, Howell A, Hurditch E, Ford A, Turner K, Watson L, Bowler H, Jackson T, Jaques C, Dyer N, Ducker S, Goodall V, Udale E. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. The Lancet Respiratory Medicine 2022. [DOI: 10.1016/s2213-2600(22)00261-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez‐castrellon P, Ma X. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Ma J, Bai H, Gong T, Mao W, Nie Y, Zhang X, Da Y, Wang X, Qin H, Zeng Q, Hu F, Qi X, Shi B, Zhang C. Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations. Immunol Lett 2022:S0165-2478(22)00117-1. [PMID: 36055412 DOI: 10.1016/j.imlet.2022.08.006] [Reference Citation Analysis]
22 Soltani-Zangbar MS, Parhizkar F, Abdollahi M, Shomali N, Aghebati-Maleki L, Shahmohammadi Farid S, Roshangar L, Mahmoodpoor A, Yousefi M. Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives. Cell Commun Signal 2022;20:131. [PMID: 36038915 DOI: 10.1186/s12964-022-00948-7] [Reference Citation Analysis]
23 Upadhyay TK, Trivedi R, Khan F, Pandey P, Sharangi AB, Goel H, Saeed M, Park MN, Kim B. Potential Therapeutic Role of Mesenchymal-Derived Stem Cells as an Alternative Therapy to Combat COVID-19 through Cytokines Storm. Cells 2022;11:2686. [DOI: 10.3390/cells11172686] [Reference Citation Analysis]
24 Awad H, Hassan B, Dweek S, Aboelata Y, Rawas-qalaji M, Ahmed IS. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022;15:1068. [DOI: 10.3390/ph15091068] [Reference Citation Analysis]
25 Bryushkova EA, Skatova VD, Mutovina ZY, Zagrebneva AI, Fomina DS, Kruglova TS, Akopyan AA, Strazhesko ID, Lukyanov SA, Tkacheva ON, Lysenko MA, Chudakov DM. Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study. PLoS ONE 2022;17:e0273340. [DOI: 10.1371/journal.pone.0273340] [Reference Citation Analysis]
26 Oza PP, Kashfi K. Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise. Nitric Oxide 2022;128:72-102. [PMID: 36029975 DOI: 10.1016/j.niox.2022.08.003] [Reference Citation Analysis]
27 Postiga IAL, Teixeira PC, Neves CAM, Santana Filho P, Marmett B, Carvalho R, Peres A, Rotta L, Thompson CE, Dorneles GP, Romão PRT. Systemic redox imbalance in severe COVID-19 patients. Cell Biochem Funct 2022. [PMID: 35980161 DOI: 10.1002/cbf.3735] [Reference Citation Analysis]
28 Pertzov B, Shapira G, Abushkara S, Cohen S, Turjeman A, Kramer MR, Gurwitz D, Shomron N. Lower serum alpha 1 antitrypsin levels in patients with severe COVID-19 compared with patients hospitalized due to non-COVID-19 pneumonia. Infect Dis (Lond) 2022;:1-6. [PMID: 35975662 DOI: 10.1080/23744235.2022.2111464] [Reference Citation Analysis]
29 Korobova ZR, Arsentieva NA, Liubimova NE, Dedkov VG, Gladkikh AS, Sharova AA, Chernykh EI, Kashchenko VA, Ratnikov VA, Gorelov VP, Stanevich OV, Kulikov AN, Pevtsov DE, Totolian AA. A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants. Int J Mol Sci 2022;23:9058. [PMID: 36012323 DOI: 10.3390/ijms23169058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Honarmand A, Sheybani F, Aflatoonian E, Saberinia A. COVID-19 patients at referral to hospital during the first peak of disease: Common clinical findings including myalgia and fatigue. Eur J Transl Myol 2021. [DOI: 10.4081/ejtm.2022.10731] [Reference Citation Analysis]
31 Ramón A, Zaragozá M, Torres AM, Cascón J, Blasco P, Milara J, Mateo J. Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab. J Clin Med 2022;11:4729. [PMID: 36012968 DOI: 10.3390/jcm11164729] [Reference Citation Analysis]
32 Philippe A, Puel M, Narjoz C, Gendron N, Durey-Dragon MA, Vedie B, Balduyck M, Chocron R, Hauw-Berlemont C, Sanchez O, Mirault T, Diehl JL, Smadja DM, Loriot MA. Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19. Biochimie 2022:S0300-9084(22)00188-2. [PMID: 35952950 DOI: 10.1016/j.biochi.2022.07.012] [Reference Citation Analysis]
33 Leither LM, Buckel W, Brown SM. Care of the Seriously Ill Patient with SARS CoV-2. Medical Clinics of North America 2022. [DOI: 10.1016/j.mcna.2022.08.002] [Reference Citation Analysis]
34 Liu C, Liu C, Fu R. Research progress on the role of PKM2 in the immune response. Front Immunol 2022;13:936967. [DOI: 10.3389/fimmu.2022.936967] [Reference Citation Analysis]
35 García-Carmona S, Falfán-Valencia R, Verónica-Aguilar A, Buendía-Roldán I, Chávez-Galán L, Hernández-Zenteno RJ, Martínez-Morales A, Fricke-Galindo I, Alanis-Ponce J, Valencia-Pérez Rea D, Gutiérrez-Pérez IA, Zaragoza-García O, Nava-Quiroz KJ, Camarena A, Mejía M, Guzmán-Guzmán IP, Pérez-Rubio G. COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B. Curr Issues Mol Biol 2022;44:3283-90. [PMID: 35892712 DOI: 10.3390/cimb44080226] [Reference Citation Analysis]
36 Lee Y, Hsu H, Yang C, Lin Y, Chang S, Yang R, Liang J, Chao T, Liao C, Kao H, Chang J, Sytwu H, Chen C, Lee S. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022;14:1511. [DOI: 10.3390/pharmaceutics14071511] [Reference Citation Analysis]
37 Khani E, Shahrabi M, Rezaei H, Pourkarim F, Afsharirad H, Solduzian M. Current evidence on the use of anakinra in COVID-19. Int Immunopharmacol 2022;111:109075. [PMID: 35905562 DOI: 10.1016/j.intimp.2022.109075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sun R, Xu Z, Zhu C, Chen T, Muñoz LE, Dai L, Zhao Y. Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects. Int Immunopharmacol 2022;110:109001. [PMID: 35803133 DOI: 10.1016/j.intimp.2022.109001] [Reference Citation Analysis]
39 Campbell GR, Rawat P, Spector SA. Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA. J Innate Immun 2022;:1-11. [PMID: 35785771 DOI: 10.1159/000525292] [Reference Citation Analysis]
40 Jafrin S, Aziz MA, Islam MS. Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are Critically Involved With the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies. Biomark Insights 2022;17:11772719221106600. [PMID: 35747885 DOI: 10.1177/11772719221106600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 McKenna E, Wubben R, Isaza-Correa JM, Melo AM, Mhaonaigh AU, Conlon N, O'Donnell JS, Ní Cheallaigh C, Hurley T, Stevenson NJ, Little MA, Molloy EJ. Neutrophils in COVID-19: Not Innocent Bystanders. Front Immunol 2022;13:864387. [PMID: 35720378 DOI: 10.3389/fimmu.2022.864387] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
42 Bozkurt B, Das SR, Addison D, Gupta A, Jneid H, Khan SS, Koromia GA, Kulkarni PA, LaPoint K, Lewis EF, Michos ED, Peterson PN, Turagam MK, Wang TY, Yancy CW; Writing Committee Members. 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol 2022:S0735-1097(22)04579-X. [PMID: 35753858 DOI: 10.1016/j.jacc.2022.03.355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Köhnlein T, Wilkens M, Eydt K. [Impact of COVID-19 pandemic on information management and adherence to replacement therapy with AAT of patients with alpha-1 antitrypsin deficiency (AATM)]. Pneumologie 2022. [PMID: 35724679 DOI: 10.1055/a-1845-0160] [Reference Citation Analysis]
44 Ebihara T, Matsumoto H, Matsubara T, Togami Y, Nakao S, Matsuura H, Onishi S, Kojima T, Sugihara F, Okuzaki D, Hirata H, Yamamura H, Ogura H. Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19. Front Immunol 2022;13:830061. [DOI: 10.3389/fimmu.2022.830061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Krysa SJ, Allen LH. Metabolic Reprogramming Mediates Delayed Apoptosis of Human Neutrophils Infected With Francisella tularensis. Front Immunol 2022;13:836754. [PMID: 35693822 DOI: 10.3389/fimmu.2022.836754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 García-Villalba J, Hurtado-Navarro L, Peñín-Franch A, Molina-López C, Martínez-Alarcón L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol 2022;13:894470. [PMID: 35663992 DOI: 10.3389/fimmu.2022.894470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Shakeeb N, Varkey P, Hynse A, Ajit A. Saliva as a Potential Specimen to Monitor IL-6, TNF-α and IL-10 in COVID-19 Patients. Inflammation 2022. [PMID: 35676607 DOI: 10.1007/s10753-022-01698-x] [Reference Citation Analysis]
48 González-Islas D, Sánchez-Moreno C, Orea-Tejeda A, Hernández-López S, Salgado-Fernández F, Keirns-Davis C, Galicia-Amor S, Trejo-Mellado E, Gochicoa-Rangel L, Castorena-Maldonado A. Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections. BMC Pulm Med 2022;22:223. [PMID: 35676657 DOI: 10.1186/s12890-022-02014-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Caird R, Williamson M, Yusuf A, Gogoi D, Casey M, McElvaney NG, Reeves EP. Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease. Int J Mol Sci 2022;23:6400. [PMID: 35742845 DOI: 10.3390/ijms23126400] [Reference Citation Analysis]
50 Karwaciak I, Karaś K, Sałkowska A, Pastwińska J, Ratajewski M. Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes. Molecules 2022;27:3651. [PMID: 35744777 DOI: 10.3390/molecules27123651] [Reference Citation Analysis]
51 Rubio-casillas A, Redwan EM, Uversky VN. SARS-CoV-2: A Master of Immune Evasion. Biomedicines 2022;10:1339. [DOI: 10.3390/biomedicines10061339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Akbasheva O, Spirina L, Dyakov D, Masunova N. Proteolysis and deficiency of α1-proteinase inhibitor in SARS-CoV-2 infection. BIOMED KHIM 2022;68:157-176. [DOI: 10.18097/pbmc20226803157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Sabetian G, Azimi A, Kazemi A, Hoseini B, Asmarian N, Khaloo V, Zand F, Masjedi M, Shahriarirad R, Shahriarirad S. Prediction of Patients with COVID-19 Requiring Intensive Care: A Cross-sectional Study Based on Machine-learning Approach from Iran. Indian Journal of Critical Care Medicine 2022;26:688-95. [DOI: 10.5005/jp-journals-10071-24226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Akın Şen İ, Karaşahin Ö, Şebin E, Şen C. Use of azurocidin (heparin binding protein) and interleukin-1ß as prognostic indicators in COVID-19 patients. Eur J Inflamm 2022;20:1721727X2211051. [DOI: 10.1177/1721727x221105129] [Reference Citation Analysis]
55 Romo EZ, Zivkovic AM. Glycosylation of HDL-Associated Proteins and Its Implications in Cardiovascular Disease Diagnosis, Metabolism and Function. Front Cardiovasc Med 2022;9:928566. [DOI: 10.3389/fcvm.2022.928566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Gorący A, Rosik J, Szostak B, Ustianowski Ł, Ustianowska K, Gorący J. Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview. Viruses 2022;14:1092. [DOI: 10.3390/v14051092] [Reference Citation Analysis]
57 Palacios Y, Chavez-galan L. Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative? Pharmaceuticals 2022;15:616. [DOI: 10.3390/ph15050616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Sun Y, Miller DC, Akpandak I, Chen EM, Arnold BF, Acharya NR. Association between immunosuppressive drugs and COVID-19 outcomes in patients with non-infectious uveitis in a large US claims database. Ophthalmology 2022:S0161-6420(22)00362-1. [PMID: 35588945 DOI: 10.1016/j.ophtha.2022.05.008] [Reference Citation Analysis]
59 Petrov VI, Ryazanova NY, Ponomareva AV, Shatalova OV, Levina YV. CLINICAL AND ECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICS CONSUMPTION BY PATIENTS WITH COVID-19. Farm farmakol (Pâtigorsk) 2022;10:198-206. [DOI: 10.19163/2307-9266-2022-10-2-198-206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 D’amato M, Vertui V, Pandolfi L, Bozzini S, Fossali T, Colombo R, Aliberti A, Fumagalli M, Iadarola P, Didò C, Viglio S, Meloni F. Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients. CIMB 2022;44:2122-38. [DOI: 10.3390/cimb44050143] [Reference Citation Analysis]
61 Bigalke A, Neu C, Esper Treml R, Coldewey SM, Kiehntopf M. Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis. Clin Chem Lab Med 2022. [PMID: 35503554 DOI: 10.1515/cclm-2022-0361] [Reference Citation Analysis]
62 Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology 2022. [PMID: 35505267 DOI: 10.1007/s10787-022-00992-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Chang Y, Bai M, You Q, Abdalla SS. Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/2755246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Lewis TC, Arnouk S, Toy B, Geraci TC, Carillo JA, Chang SH, Moazami N, Kon ZN, Smith DE. Tocilizumab Accelerates Recovery in Patients With Severe COVID-19 Pneumonia on Venovenous Extracorporeal Membrane Oxygenation. ASAIO J 2022. [PMID: 35483095 DOI: 10.1097/MAT.0000000000001707] [Reference Citation Analysis]
65 Alshammary AF, Alsughayyir JM, Alharbi KK, Al-sulaiman AM, Alshammary HF, Alshammary HF. T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med 2022;9:852749. [DOI: 10.3389/fmed.2022.852749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Hasselbach L, Weidner J, Elsässer A, Theilmeier G. Heart Failure Relapses in Response to Acute Stresses – Role of Immunological and Inflammatory Pathways. Front Cardiovasc Med 2022;9:809935. [DOI: 10.3389/fcvm.2022.809935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Tuvali O, Tshori S, Derazne E, Hannuna RR, Afek A, Haberman D, Sella G, George J. The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study. JCM 2022;11:2219. [DOI: 10.3390/jcm11082219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
68 Singh A, Chidharla A, Agarwal K, Singh P, Jain N, Hassen G, Abdelwahed S, Bhandari R, Patel K, Gupta S, Koritala T, Rabbani R. Vitamin D: The Missing Nutrient Behind the Two Deadly Pandemics, COVID-19 and Cardiovascular Diseases. Cureus 2022. [DOI: 10.7759/cureus.24133] [Reference Citation Analysis]
69 Ahmad R, Haque M. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction. Vaccines (Basel) 2022;10:614. [PMID: 35455363 DOI: 10.3390/vaccines10040614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
70 Dolci M, Signorini L, D'Alessandro S, Perego F, Parapini S, Sommariva M, Taramelli D, Ferrante P, Basilico N, Delbue S. In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release. Int J Mol Sci 2022;23:4063. [PMID: 35409421 DOI: 10.3390/ijms23074063] [Reference Citation Analysis]
71 Chaves DG, de Oliveira LC, da Silva Malta MCF, de Oliveira IR, Barbosa-Stancioli EF, Teixeira MM, Martins ML. Pro-inflammatory immune profile mediated by TNF and IFN-γ and regulated by IL-10 is associated to IgG anti-SARS-CoV-2 in asymptomatic blood donors. Cytokine 2022;154:155874. [PMID: 35397248 DOI: 10.1016/j.cyto.2022.155874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Goel K, Serban KA. The multifaceted protease-anti-protease imbalance in COVID-19. eBioMedicine 2022;78:103973. [DOI: 10.1016/j.ebiom.2022.103973] [Reference Citation Analysis]
73 Yao L, Lu L, Ma W. Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients. Heliyon 2022;8:e09302. [PMID: 35497026 DOI: 10.1016/j.heliyon.2022.e09302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Zhu J, Zhang H, Lin Q, Lyu J, Lu L, Chen H, Zhang X, Zhang Y, Chen K. Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds. DDDT 2022;Volume 16:1067-1082. [DOI: 10.2147/dddt.s359009] [Reference Citation Analysis]
75 Snow TAC, Longobardo A, Brealey D, Down J, Satta G, Singer M, Arulkumaran N. Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.04.001] [Reference Citation Analysis]
76 Rosen DB, Murphy EA, Gejman RS, Capili A, Friedlander RL, Rand S, Cagino KA, Glynn SM, Matthews KC, Kubiak JM, Yee J, Prabhu M, Riley LE, Yang YJ. Cytokine response over the course of COVID-19 infection in pregnant women. Cytokine 2022. [DOI: 10.1016/j.cyto.2022.155894] [Reference Citation Analysis]
77 Allen CNS, Arjona SP, Santerre M, De Lucia C, Koch WJ, Sawaya BE. Metabolic Reprogramming in HIV-Associated Neurocognitive Disorders. Front Cell Neurosci 2022;16:812887. [DOI: 10.3389/fncel.2022.812887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Bai X, Buckle AM, Vladar EK, Janoff EN, Khare R, Ordway D, Beckham D, Fornis LB, Majluf-Cruz A, Fugit RV, Freed BM, Kim S, Sandhaus RA, Chan ED. Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. Sci Rep 2022;12:5207. [PMID: 35338216 DOI: 10.1038/s41598-022-09133-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
79 Li YR, Dunn ZS, Garcia G Jr, Carmona C, Zhou Y, Lee D, Yu J, Huang J, Kim JT, Arumugaswami V, Wang P, Yang L. Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention. Stem Cell Res Ther 2022;13:112. [PMID: 35313965 DOI: 10.1186/s13287-022-02787-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
80 Hemachudha P, Pongpitakmetha T, Rattanawong W, Thanapornsungsuth P, Joyjinda Y, Bunprakob S, Ruchisrisarod C, Hemachudha T. A case of successive development of possible acute necrotizing encephalopathy after COVID-19 pneumonia. SAGE Open Medical Case Reports 2022;10:2050313X2210836. [DOI: 10.1177/2050313x221083653] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Chieregato M, Frangiamore F, Morassi M, Baresi C, Nici S, Bassetti C, Bnà C, Galelli M. A hybrid machine learning/deep learning COVID-19 severity predictive model from CT images and clinical data. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07890-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
82 Stojkov D, Gigon L, Peng S, Lukowski R, Ruth P, Karaulov A, Rizvanov A, Barlev NA, Yousefi S, Simon HU. Physiological and Pathophysiological Roles of Metabolic Pathways for NET Formation and Other Neutrophil Functions. Front Immunol 2022;13:826515. [PMID: 35251008 DOI: 10.3389/fimmu.2022.826515] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
83 Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R, Bernasconi MP, Castelnovo V, Cividini C, Cursi M, Vabanesi M, Impellizzeri M, Lazzarin SM, Fanelli GF, Minicucci F, Giacalone G, Falini A, Falautano M, Rovere-querini P, Roveri L, Filippi M. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol. [DOI: 10.1007/s00415-022-11047-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
84 Abusalah MAH, Khalifa M, Al-hatamleh MAI, Jarrar M, Mohamud R, Chan YY. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. JPM 2022;12:386. [DOI: 10.3390/jpm12030386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
85 Papadopoulou G, Manoloudi E, Repousi N, Skoura L, Hurst T, Karamitros T. Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Pathogens 2022;11:311. [DOI: 10.3390/pathogens11030311] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
86 Akelew Y, Andualem H, Ebrahim E, Atnaf A, Hailemichael W. Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA. The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival. IDR 2022;Volume 15:821-9. [DOI: 10.2147/idr.s348392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Masotti L, Landini G, Panigada G, Grifoni E, Tarquini R, Cei F, Maria Angela Cimolato B, Vannucchi V, Di Pietro M, Piani F, Fortini A, Faraone A, Nenci G, Cipollini F, Blanc P, Lotti P, Di Natale M, Risaliti F, Aquilini D, Seravalle C, Bribani A, Farsi A, Micheletti I, Cioni E, Pelagalli G, Mattaliano C, Pinto G, Maria Madonia E, Sivieri I, Mannini M, Valoriani A, Brancati S, Rosselli M, Pavone E, Chiara Burla M, Sergi A. PREDICTORS OF POOR OUTCOME IN TOCILIZUMAB TREATED PATIENTS WITH SARS-CoV-2 RELATED SEVERE RESPIRATORY FAILURE: A MULTICENTRE REAL WORLD STUDY. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Özgeriş FB, Koçak ÖF, Kurt N, Parlak E, Yüce N, Keleş MS. High Serum Progranulin Levels in COVID-19 Patients: A Pilot Study. Biochemistry Moscow 2022;87:207-214. [DOI: 10.1134/s0006297922030026] [Reference Citation Analysis]
90 McElvaney OF, Asakura T, Meinig SL, Torres-Castillo JL, Hagan RS, Gabillard-Lefort C, Murphy MP, Thorne LB, Borczuk A, Reeves EP, Zumwalt RE, Mikami Y, Carroll TP, Okuda K, Hogan G, McElvaney OJ, Clarke J, McEvoy NL, Mallon PW, McCarthy C, Curley G, Wolfgang MC, Boucher RC, McElvaney NG. Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications. EBioMedicine 2022;77:103894. [PMID: 35217407 DOI: 10.1016/j.ebiom.2022.103894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
91 Richter RP, Joiner DM, Griffin RL, Jansen JO, Kerby JD, Wade CE, Holcomb JB, Cardenas JC, Richter JR. Endotheliopathy Is Associated With a 24-Hour Fibrinolysis Phenotype Described by Low TEG Lysis and High d-Dimer After Trauma: A Secondary Analysis of the PROPPR Study. Annals of Surgery Open 2022;3:e116. [DOI: 10.1097/as9.0000000000000116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 O'Brien ME, Murray G, Gogoi D, Yusuf A, McCarthy C, Wormald MR, Casey M, Gabillard-Lefort C, McElvaney NG, Reeves EP. A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application. Int J Mol Sci 2022;23:2441. [PMID: 35269582 DOI: 10.3390/ijms23052441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Meyer AA, Mathews EH, Gous AGS, Mathews MJ. Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications. Front Cardiovasc Med 2022;9:737592. [DOI: 10.3389/fcvm.2022.737592] [Reference Citation Analysis]
94 Ebihara T, Matsumoto H, Matsubara T, Togami Y, Nakao S, Matsuura H, Kojima T, Sugihara F, Okuzaki D, Hirata H, Yamamura H, Ogura H. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis. Front Immunol 2021;12:798338. [PMID: 35095877 DOI: 10.3389/fimmu.2021.798338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
95 Montini L, Antonelli M. Postacute COVID-19: a new priority for health care systems. Minerva Anestesiol 2022;88. [DOI: 10.23736/s0375-9393.21.16388-6] [Reference Citation Analysis]
96 Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Mantelli F, Allegretti M, Balk RA. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome. Front Pharmacol 2021;12:808797. [PMID: 35095519 DOI: 10.3389/fphar.2021.808797] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
97 Winning S, Fandrey J. OXYGEN SENSING IN INNATE IMMUNE CELLS - HOW INFLAMMATION BROADENS CLASSICAL HIF REGULATION IN MYELOID CELLS. Antioxid Redox Signal 2022. [PMID: 35088604 DOI: 10.1089/ars.2022.0004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Zhang L, Li M, Wang Z, Sun P, Wei S, Zhang C, Wu H, Bai H. Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis. Front Immunol 2021;12:780804. [PMID: 35069552 DOI: 10.3389/fimmu.2021.780804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
99 Sokologorskiy SV, Ovechkin AM, Khapov IV, Politov ME, Bulanova EL. Risk Factors of Severe Disease and Methods for Clinical Outcome Prediction in Patients with COVID-19 (Review). Obŝaâ reanimatologiâ 2022;18:31-38. [DOI: 10.15360/1813-9779-2022-1-31-38] [Reference Citation Analysis]
100 Li S, Zhao F, Ye J, Li K, Wang Q, Du Z, Yue Q, Wang S, Wu Q, Chen H. Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19. Med Microbiol Immunol 2022;211:49-69. [PMID: 35022857 DOI: 10.1007/s00430-021-00727-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
101 Soares MN, Eggelbusch M, Naddaf E, Gerrits KHL, van der Schaaf M, van den Borst B, Wiersinga WJ, van Vugt M, Weijs PJM, Murray AJ, Wüst RCI. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J Cachexia Sarcopenia Muscle 2022;13:11-22. [PMID: 34997689 DOI: 10.1002/jcsm.12896] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 21.0] [Reference Citation Analysis]
102 Gao Q, Zhang W, Li T, Yang G, Zhu W, Chen N, Jin H. Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network. Sci Rep 2022;12:188. [PMID: 34996987 DOI: 10.1038/s41598-021-03912-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
103 Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol 2022;7:eabm5505. [PMID: 34995097 DOI: 10.1126/sciimmunol.abm5505] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 42.0] [Reference Citation Analysis]
104 Mizurini DM, Hottz ED, Bozza PT, Monteiro RQ. Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects. Front Cardiovasc Med 2021;8:785738. [PMID: 34977191 DOI: 10.3389/fcvm.2021.785738] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
105 Shen Q, Li J, Zhang Z, Guo S, Wang Q, An X, Chang H. COVID-19: systemic pathology and its implications for therapy. Int J Biol Sci 2022;18:386-408. [PMID: 34975340 DOI: 10.7150/ijbs.65911] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
106 Giamarellos-bourboulis EJ, Mouktaroudi M, Netea MG. Hit Early: Blocking Interleukin-1 in the Treatment of COVID-19 Pneumonia. Annual Update in Intensive Care and Emergency Medicine 2022. [DOI: 10.1007/978-3-030-93433-0_3] [Reference Citation Analysis]
107 Nguyen VT, Chan LS. COVID-19 Infection: The Virus and Its Origin, the Variants, the Immune Defense, the Multiorgan Autoimmune Reactions, and the Targeted Treatments. AID 2022;12:568-631. [DOI: 10.4236/aid.2022.123042] [Reference Citation Analysis]
108 Mairpady Shambat S, Gómez-Mejia A, Schweizer TA, Huemer M, Chang CC, Acevedo C, Bergada-Pijuan J, Vulin C, Hofmaenner DA, Scheier TC, Hertegonne S, Parietti E, Miroshnikova N, Wendel Garcia PD, Hilty MP, Buehler PK, Schuepbach RA, Brugger SD, Zinkernagel AS. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19. PLoS Pathog 2022;18:e1010176. [PMID: 35007290 DOI: 10.1371/journal.ppat.1010176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
109 Panda NK, Sharma M, Ramavat AS, Patro SK, Nayak GR, Kaushal K. Novel Cellular Stress Models with Implications in Understanding and Treating ENT Pathologies. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-8845-4_7] [Reference Citation Analysis]
110 Harbi SA, Alfaifi M, Al-dorzi HM, Aljuhani O, Alenazi AA, Alalawi M, Sulaiman KA. A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient. IDCases 2022;29:e01572. [DOI: 10.1016/j.idcr.2022.e01572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 González-Andrade F. Post-COVID-19 conditions in Ecuadorian patients: an observational study. Lancet Reg Health Am 2022;5:100088. [PMID: 34870261 DOI: 10.1016/j.lana.2021.100088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
112 Masterson CH, Ceccato A, Artigas A, Dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, Curley GF, Laffey JG. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp 2021;9:61. [PMID: 34970706 DOI: 10.1186/s40635-021-00424-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Basin S, Valentin S, Maurac A, Poussel M, Pequignot B, Brindel A, Poupet G, Robert C, Baumann C, Luc A, Soler J, Chabot F, Chaouat A. Progression to a severe form of COVID-19 among patients with chronic respiratory diseases. Respir Med Res 2021;81:100880. [PMID: 34974204 DOI: 10.1016/j.resmer.2021.100880] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Berman E, Noyman I, Medvedovsky M, Ekstein D, Eyal S. Not your usual drug-drug interactions: Monoclonal antibody-based therapeutics may interact with antiseizure medications. Epilepsia 2021. [PMID: 34967010 DOI: 10.1111/epi.17147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Cioccarelli C, Sánchez-Rodríguez R, Angioni R, Venegas FC, Bertoldi N, Munari F, Cattelan A, Molon B, Viola A. IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis. Front Immunol 2021;12:781352. [PMID: 34950146 DOI: 10.3389/fimmu.2021.781352] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
117 Melton A, Doyle-Meyers LA, Blair RV, Midkiff C, Melton HJ, Russell-Lodrigue K, Aye PP, Schiro F, Fahlberg M, Szeltner D, Spencer S, Beddingfield BJ, Goff K, Golden N, Penney T, Picou B, Hensley K, Chandler KE, Plante JA, Plante KS, Weaver SC, Roy CJ, Hoxie JA, Gao H, Montefiori DC, Mankowski JL, Bohm RP, Rappaport J, Maness NJ. The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease. PLoS Pathog 2021;17:e1010162. [PMID: 34929014 DOI: 10.1371/journal.ppat.1010162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
118 Ren Z, Yu Y, Chen C, Yang D, Ding T, Zhu L, Deng J, Xu Z. The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis. Front Microbiol 2021;12:807737. [PMID: 34917069 DOI: 10.3389/fmicb.2021.807737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
119 Kanorskii SG. Post-COVID syndrome: prevalence, organ pathogenesis and routes of correction. A systematic review. Kuban nauсh med vestnik 2021;28:90-116. [DOI: 10.25207/1608-6228-2021-28-6-90-116] [Reference Citation Analysis]
120 Borella R, De Biasi S, Paolini A, Boraldi F, Lo Tartaro D, Mattioli M, Fidanza L, Neroni A, Caro-Maldonado A, Meschiari M, Franceschini E, Quaglino D, Guaraldi G, Bertoldi C, Sita M, Busani S, Girardis M, Mussini C, Cossarizza A, Gibellini L. Metabolic reprograming shapes neutrophil functions in severe COVID-19. Eur J Immunol 2021. [PMID: 34870329 DOI: 10.1002/eji.202149481] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
121 Timmons GA, Carroll RG, O'Siorain JR, Cervantes-Silva MP, Fagan LE, Cox SL, Palsson-McDermott E, Finlay DK, Vincent EE, Jones N, Curtis AM. The Circadian Clock Protein BMAL1 Acts as a Metabolic Sensor In Macrophages to Control the Production of Pro IL-1β. Front Immunol 2021;12:700431. [PMID: 34858390 DOI: 10.3389/fimmu.2021.700431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
122 Mohamed Ali S, Musa A, Omar Muhammed K, Javed S, Al Raqabani M, Adnan Baradie B, Sobhi Gargousa M, Osman OA, AlDeen Roqia S, Lakshmanan J, Al Hashemi H, Omar Baslaib F. Prolonged corrected QT interval in hospitalized patients with coronavirus disease 2019 in Dubai, United Arab Emirates: a single-center, retrospective study. J Int Med Res 2021;49:3000605211056834. [PMID: 34851769 DOI: 10.1177/03000605211056834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
123 Hu J, Han Z, Heidari AA, Shou Y, Ye H, Wang L, Huang X, Chen H, Chen Y, Wu P. Detection of COVID-19 severity using blood gas analysis parameters and Harris hawks optimized extreme learning machine. Computers in Biology and Medicine 2021. [DOI: 10.1016/j.compbiomed.2021.105166] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 29.0] [Reference Citation Analysis]
124 Asawapattanakul T, Pintapagung T, Piratae S, Juntautsa S, Chancharoen P. Erythrocyte sedimentation rate, C-reactive protein, and interleukin-6 as inflammatory biomarkers in dogs naturally infected with Ehrlichia canis. Vet World 2021;14:2325-31. [PMID: 34840450 DOI: 10.14202/vetworld.2021.2325-2331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Hadi C, Pramana C. Profile of COVID-19 Patients in Dr. Moewardi Hospital Surakarta Indonesia. Open Access Maced J Med Sci 2021;9:1621-1624. [DOI: 10.3889/oamjms.2021.7522] [Reference Citation Analysis]
126 Mabrey FL, Morrell ED, Wurfel MM. TLRs in COVID-19: How they drive immunopathology and the rationale for modulation. Innate Immun 2021;27:503-13. [PMID: 34806446 DOI: 10.1177/17534259211051364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
127 Lai Y, Han T, Lao Z, Li G, Xiao J, Liu X. Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis. Front Pharmacol 2021;12:754241. [PMID: 34803696 DOI: 10.3389/fphar.2021.754241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Sansone A, Mollaioli D, Limoncin E, Ciocca G, Bắc NH, Cao TN, Hou G, Yuan J, Zitzmann M, Giraldi A, Jannini EA. The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers. Sex Med Rev 2021:S2050-0521(21)00085-8. [PMID: 34933829 DOI: 10.1016/j.sxmr.2021.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
129 Meyerholz DK, Reznikov LR. Influence of SARS-CoV-2 on airway mucus production: A review and proposed model. Vet Pathol 2021;:3009858211058837. [PMID: 34794359 DOI: 10.1177/03009858211058837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
130 Monserrat J, Asunsolo A, Gómez-Lahoz A, Ortega MA, Gasalla JM, Gasulla Ó, Fortuny-Profitós J, Mazaira-Font FA, Teixidó Román M, Arranz A, Sanz J, Muñoz B, Arévalo-Serrano J, Rodríguez JM, Martínez-A C, Balomenos D, Álvarez-Mon M. Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19. Biomedicines 2021;9:1675. [PMID: 34829906 DOI: 10.3390/biomedicines9111675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
131 Liu Z, Le Y, Chen H, Zhu J, Lu D. Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm. Front Immunol 2021;12:748573. [PMID: 34759927 DOI: 10.3389/fimmu.2021.748573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
132 Herth FJF, Sandhaus RA, Turner AM, Sucena M, Welte T, Greulich T. Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic. Int J Chron Obstruct Pulmon Dis 2021;16:2983-96. [PMID: 34754184 DOI: 10.2147/COPD.S325211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
133 Lin L, Chen X, Chen J, Pan X, Xia P, Lin H, Du H. The predictive value of serum level of cystatin C for COVID-19 severity. Sci Rep 2021;11:21964. [PMID: 34754069 DOI: 10.1038/s41598-021-01570-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Declercq J, Van Damme KFA, De Leeuw E, Maes B, Bosteels C, Tavernier SJ, De Buyser S, Colman R, Hites M, Verschelden G, Fivez T, Moerman F, Demedts IK, Dauby N, De Schryver N, Govaerts E, Vandecasteele SJ, Van Laethem J, Anguille S, van der Hilst J, Misset B, Slabbynck H, Wittebole X, Liénart F, Legrand C, Buyse M, Stevens D, Bauters F, Seys LJM, Aegerter H, Smole U, Bosteels V, Hoste L, Naesens L, Haerynck F, Vandekerckhove L, Depuydt P, van Braeckel E, Rottey S, Peene I, Van Der Straeten C, Hulstaert F, Lambrecht BN. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial. Lancet Respir Med 2021:S2213-2600(21)00377-5. [PMID: 34756178 DOI: 10.1016/S2213-2600(21)00377-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 24.0] [Reference Citation Analysis]
135 Won SY, Seol IC, Yoo HR, Kim YS. Antiviral Effect of Hyunggaeyungyo-Tang on A549 Cells Infected with Human Coronavirus. Evid Based Complement Alternat Med 2021;2021:4494389. [PMID: 34659433 DOI: 10.1155/2021/4494389] [Reference Citation Analysis]
136 RECOVERY Collaborative Group. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med 2021:S2213-2600(21)00435-5. [PMID: 34672950 DOI: 10.1016/S2213-2600(21)00435-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 62] [Article Influence: 48.0] [Reference Citation Analysis]
137 Sancho Ferrando E, Hanslin K, Hultström M, Larsson A, Frithiof R, Lipcsey M; Uppsala Intensive Care COVID-19 Research Group. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study. Cytokine 2022;149:155727. [PMID: 34628127 DOI: 10.1016/j.cyto.2021.155727] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
138 Combadière B, Adam L, Guillou N, Quentric P, Rosenbaum P, Dorgham K, Bonduelle O, Parizot C, Sauce D, Mayaux J, Luyt CE, Boissonnas A, Amoura Z, Pourcher V, Miyara M, Gorochov G, Guihot A, Combadière C. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications. Front Immunol 2021;12:752612. [PMID: 34616409 DOI: 10.3389/fimmu.2021.752612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
139 Rosas IO, Diaz G, Gottlieb RL, Lobo SM, Robinson P, Hunter BD, Cavalcante AW, Overcash JS, Hanania NA, Skarbnik A, Garcia-Diaz J, Gordeev I, Carratalà J, Gordon O, Graham E, Lewin-Koh N, Tsai L, Tuckwell K, Cao H, Brainard D, Olsson JK. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med 2021;47:1258-70. [PMID: 34609549 DOI: 10.1007/s00134-021-06507-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 31.0] [Reference Citation Analysis]
140 Bein K, Birru RL, Wells H, Larkin TP, Ge T, Leikauf GD. Sex-dependent acrolein sensitivity in mice is associated with differential lung cell, protein, and transcript changes. Physiol Rep 2021;9:e14997. [PMID: 34605213 DOI: 10.14814/phy2.14997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Lombardi Y, Azoyan L, Szychowiak P, Bellamine A, Lemaitre G, Bernaux M, Daniel C, Leblanc J, Riller Q, Steichen O; AP-HP/Universities/INSERM COVID-19 Research Collaboration AP-HP COVID CDR Initiative. External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals. Intensive Care Med 2021;47:1426-39. [PMID: 34585270 DOI: 10.1007/s00134-021-06524-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
142 Vianello A, Guarnieri G, Braccioni F, Molena B, Lococo S, Achille A, Lionello F, Salviati L, Caminati M, Senna G. Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses. J Clin Med 2021;10:4493. [PMID: 34640510 DOI: 10.3390/jcm10194493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
143 Herr C, Mang S, Mozafari B, Guenther K, Speer T, Seibert M, Srikakulam SK, Beisswenger C, Ritzmann F, Keller A, Mueller R, Smola S, Eisinger D, Zemlin M, Danziger G, Volk T, Hoersch S, Krawczyk M, Lammert F, Adams T, Wagenpfeil G, Kindermann M, Marcu C, Ataya ZWD, Mittag M, Schwarzkopf K, Custodis F, Grandt D, Schaefer H, Eltges K, Lepper PM, Bals R; CORSAAR Study Group. Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19. J Inflamm Res 2021;14:4651-67. [PMID: 34552347 DOI: 10.2147/JIR.S320685] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
144 Dorneles GP, Teixeira PC, da Silva IM, Schipper LL, Santana Filho PC, Rodrigues Júnior LC, Bonorino C, Peres A, Gonçalves Fonseca S, Monteiro MC, Boeck CR, Eller S, Oliveira TF, Wendland EM, Romão PRT. Alterations in CD39/CD73 Axis of T cells associated with COVID-19 severity.. [DOI: 10.1101/2021.09.18.21263782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
145 Krysko O, Kondakova E, Vershinina O, Galova E, Blagonravova A, Gorshkova E, Bachert C, Ivanchenko M, Krysko DV, Vedunova M. Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study. Front Immunol 2021;12:715072. [PMID: 34539644 DOI: 10.3389/fimmu.2021.715072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
146 Kukes IV, Salmasi JM, Ternovoy KS, Kazimirskii AN, Obodzinskaya TE, Lim VG, Glagovskiy PB, Mamedov IS, Poryadin GV, Savicheva AS, Kukes EA, Ptitsyn MS, Andreev AD. Prerequisites for the creation of an atlas of postcovid inflammation as a way of personalized pharmacotherapy, as well as predicting and preventing organ and systemic dysfunctions. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-12-72-88] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Galván-Peña S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, Magnuson AM, Chen F, Manickas-Hill Z, Piechocka-Trocha A, Worrall DP, Hall KE, Ghebremichael M, Walker BD, Li JZ, Yu XG, Mathis D, Benoist C; MGH COVID-19 Collection & Processing Team. Profound Treg perturbations correlate with COVID-19 severity. Proc Natl Acad Sci U S A 2021;118:e2111315118. [PMID: 34433692 DOI: 10.1073/pnas.2111315118] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 40.0] [Reference Citation Analysis]
148 Hsu HY, Yang CW, Lee YZ, Lin YL, Chang SY, Yang RB, Liang JJ, Chao TL, Liao CC, Kao HC, Wu SH, Chang JY, Sytwu HK, Chen CT, Lee SJ. Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2. Front Pharmacol 2021;12:706901. [PMID: 34483914 DOI: 10.3389/fphar.2021.706901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
149 Ercin U, Turk Aribas E, Tuncbilek S, Kaya C, Sepici Dincel A, Bilgihan A, Tekeli ME. Comparison of biochemical and immunological biomarker levels of patients with COVID-19 with healthy individuals. Turkish Journal of Biochemistry 2021;46:367-375. [DOI: 10.1515/tjb-2020-0624] [Reference Citation Analysis]
150 Arthur JM, Forrest JC, Boehme KW, Kennedy JL, Owens S, Herzog C, Liu J, Harville TO. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One 2021;16:e0257016. [PMID: 34478478 DOI: 10.1371/journal.pone.0257016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 31.0] [Reference Citation Analysis]
151 Melton A, Doyle-meyers LA, Blair RV, Midkiff C, Melton HJ, Russell-lodrigue K, Aye PP, Schiro F, Fahlberg M, Szeltner D, Spencer S, Beddingfield BJ, Goff K, Golden N, Penney T, Picou B, Hensley K, Chandler KE, Plante JA, Plante KS, Weaver SC, Roy CJ, Hoxie JA, Gao H, Montefiori DC, Mankowski JL, Bohm RP, Rappaport J, Maness NJ. The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease.. [DOI: 10.1101/2021.08.28.458047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Karonova TL, Andreeva AT, Golovatuk KA, Bykova ES, Simanenkova AV, Vashukova MA, Grant WB, Shlyakhto EV. Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19. Nutrients 2021;13:3021. [PMID: 34578898 DOI: 10.3390/nu13093021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
153 Palmas F, Clarke J, Colas RA, Gomez EA, Keogh A, Boylan M, McEvoy N, McElvaney OJ, McElvaney O, Alalqam R, McElvaney NG, Curley GF, Dalli J. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS One 2021;16:e0256226. [PMID: 34437568 DOI: 10.1371/journal.pone.0256226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
154 Islam A, Bashir MS, Joyce K, Rashid H, Laher I, Elshazly S. An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations. Molecules 2021;26:5004. [PMID: 34443589 DOI: 10.3390/molecules26165004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
155 Guan S, Darmstädter M, Xu C, Rosenecker J. In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment. Pharmaceutics 2021;13:1281. [PMID: 34452241 DOI: 10.3390/pharmaceutics13081281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
156 Subramaniyan B, Larabee JL, Bodas M, Moore AR, Burgett AWG, Myers DA, Georgescu C, Wren JD, Papin JF, Walters MS. Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals. Viruses 2021;13:1603. [PMID: 34452468 DOI: 10.3390/v13081603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
157 Palacios Y, Ruiz A, Ramón-Luing LA, Ocaña-Guzman R, Barreto-Rodriguez O, Sánchez-Monciváis A, Tecuatzi-Cadena B, Regalado-García AG, Pineda-Gudiño RD, García-Martínez A, Juárez-Hernández F, Farias-Contreras JP, Fricke-Galindo I, Pérez-Rubio G, Falfán-Valencia R, Buendia-Roldan I, Medina-Quero K, Chavez-Galan L. Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality. Int J Mol Sci 2021;22:8423. [PMID: 34445140 DOI: 10.3390/ijms22168423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
158 Wang X, Wen Y, Xie X, Liu Y, Tan X, Cai Q, Zhang Y, Cheng L, Xu G, Zhang S, Wang H, Wei L, Tang X, Qi F, Zhao J, Yuan J, Liu L, Zhu P, Ginhoux F, Zhang S, Cheng T, Zhang Z. Dysregulated hematopoiesis in bone marrow marks severe COVID-19. Cell Discov 2021;7:60. [PMID: 34349096 DOI: 10.1038/s41421-021-00296-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
159 Tumpara S, Gründing AR, Sivaraman K, Wrenger S, Olejnicka B, Welte T, Wurm MJ, Pino P, Kiseljak D, Wurm FM, Janciauskiene S. Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin. Int J Mol Sci 2021;22:7941. [PMID: 34360706 DOI: 10.3390/ijms22157941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Szakmany T, Tuckwell W, Harte E, Wetherall N, Ramachandran S, Price S, Breen H, Killick C, Cheema Y, King C, Richards O. Differences in Inflammatory Marker Kinetics between the First and Second Wave of COVID-19 Patients Admitted to the ICU: A Retrospective, Single-Center Study. J Clin Med 2021;10:3290. [PMID: 34362074 DOI: 10.3390/jcm10153290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
161 Purja S, Shin H, Lee JY, Kim E. Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis. Arch Pharm Res 2021;44:725-40. [PMID: 34302637 DOI: 10.1007/s12272-021-01344-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
162 Kuperberg SJ, Navetta-Modrov B. The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness. Am J Respir Cell Mol Biol 2021;65:13-21. [PMID: 33797351 DOI: 10.1165/rcmb.2020-0236TR] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
163 Rawat S, Vrati S, Banerjee A. Neutrophils at the crossroads of acute viral infections and severity. Mol Aspects Med 2021;:100996. [PMID: 34284874 DOI: 10.1016/j.mam.2021.100996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
164 Meng F, Siu GK, Mok BW, Sun J, Fung KSC, Lam JY, Wong NK, Gedefaw L, Luo S, Lee TMH, Yip SP, Huang CL. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells. Cells 2021;10:1762. [PMID: 34359932 DOI: 10.3390/cells10071762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
165 de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, Marchio A, Kergoat L, Hardy D, Cokelaer T, Pineau P, Lecuit M, Lledo PM, Changeux JP, Bourhy H. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin. EMBO Mol Med 2021;13:e14122. [PMID: 34170074 DOI: 10.15252/emmm.202114122] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
166 Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther 2021;6:255. [PMID: 34234112 DOI: 10.1038/s41392-021-00679-0] [Cited by in Crossref: 151] [Cited by in F6Publishing: 165] [Article Influence: 151.0] [Reference Citation Analysis]
167 Brojakowska A, Eskandari A, Bisserier M, Bander J, Garikipati VNS, Hadri L, Goukassian DA, Fish KM. Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients. PLoS One 2021;16:e0253660. [PMID: 34228746 DOI: 10.1371/journal.pone.0253660] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
168 Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol 2021;12:686029. [PMID: 34276671 DOI: 10.3389/fimmu.2021.686029] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 52.0] [Reference Citation Analysis]
169 Alladina JW, Giacona FL, White EB, Brait KL, Abe EA, Michelhaugh SA, Hibbert KA, Januzzi JL, Thompson BT, Cho JL, Medoff BD. Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure. Crit Care Explor 2021;3:e0480. [PMID: 34235459 DOI: 10.1097/CCE.0000000000000480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Teixeira PC, Dorneles GP, Filho PCS, Silva IMD, Schipper LL, Postiga IA, Moreira Neves CA, Rodrigues Júnior LC, Peres A, de Souto JT, da Fonseca SG, Eller S, Oliveira TF, Rotta LN, Thompson C, Romão PRT. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients.. [DOI: 10.1101/2021.06.24.21259468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
171 Takayama S, Namiki T, Odaguchi H, Arita R, Hisanaga A, Mitani K, Ito T. Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials. Front Pharmacol 2021;12:656246. [PMID: 34248620 DOI: 10.3389/fphar.2021.656246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
172 Pandolfi L, Bozzini S, Frangipane V, Percivalle E, De Luigi A, Violatto MB, Lopez G, Gabanti E, Carsana L, D'Amato M, Morosini M, De Amici M, Nebuloni M, Fossali T, Colombo R, Saracino L, Codullo V, Gnecchi M, Bigini P, Baldanti F, Lilleri D, Meloni F. Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis. Front Immunol 2021;12:663303. [PMID: 34194429 DOI: 10.3389/fimmu.2021.663303] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
173 Tan Y, Zhang W, Zhu Z, Qiao N, Ling Y, Guo M, Yin T, Fang H, Xu X, Lu G, Zhang P, Yang S, Fu Z, Liang D, Xie Y, Zhang R, Jiang L, Yu S, Lu J, Jiang F, Chen J, Xiao C, Wang S, Chen S, Bian XW, Lu H, Liu F, Chen S. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19. Cell Discov 2021;7:42. [PMID: 34103487 DOI: 10.1038/s41421-021-00274-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
174 Attia N, Mashal M, Puras G, Pedraz JL. Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects. Pharmaceutics 2021;13:843. [PMID: 34200425 DOI: 10.3390/pharmaceutics13060843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
175 Clemente-Suárez VJ, Ramos-Campo DJ, Mielgo-Ayuso J, Dalamitros AA, Nikolaidis PA, Hormeño-Holgado A, Tornero-Aguilera JF. Nutrition in the Actual COVID-19 Pandemic. A Narrative Review. Nutrients 2021;13:1924. [PMID: 34205138 DOI: 10.3390/nu13061924] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 38.0] [Reference Citation Analysis]
176 O'Carroll SM, O'Neill LAJ. Targeting immunometabolism to treat COVID-19. Immunother Adv 2021;1:ltab013. [PMID: 34240083 DOI: 10.1093/immadv/ltab013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
177 Hazeldine J, Lord JM. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets. Front Immunol 2021;12:680134. [PMID: 34149717 DOI: 10.3389/fimmu.2021.680134] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
178 Ambardar SR, Hightower SL, Huprikar NA, Chung KK, Singhal A, Collen JF. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. J Clin Med 2021;10:2452. [PMID: 34205928 DOI: 10.3390/jcm10112452] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 36.0] [Reference Citation Analysis]
179 Larsson SC, Gill D. Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19. Allergy 2021;76:1911-3. [PMID: 33382452 DOI: 10.1111/all.14728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
180 Gong J, Wang DK, Dong H, Xia QS, Huang ZY, Zhao Y, Chen X, Yuan F, Li JB, Lu FE. Prognostic significance of low TSH concentration in patients with COVID-19 presenting with non-thyroidal illness syndrome. BMC Endocr Disord 2021;21:111. [PMID: 34044831 DOI: 10.1186/s12902-021-00766-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
181 Kuindersma M, Diaz RR, Spronk PE. Tailored modulation of the inflammatory balance in COVID-19 patients admitted to the ICU?-a viewpoint. Crit Care 2021;25:178. [PMID: 34034789 DOI: 10.1186/s13054-021-03607-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
182 Pérez JMH, Gonçálves JMF, Fariña YR. Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection. Arch Med Sci 2021;17:1134-6. [PMID: 34336044 DOI: 10.5114/aoms/136562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Snow TAC, Saleem N, Ambler G, Nastouli E, Singer M, Arulkumaran N. Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials. Intensive Care Med 2021;47:641-52. [PMID: 34019122 DOI: 10.1007/s00134-021-06416-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 31.0] [Reference Citation Analysis]
184 Yin J, Wang S, Liu Y, Chen J, Li D, Xu T. Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation 2021;:e12718. [PMID: 34013612 DOI: 10.1111/micc.12718] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
185 Nossent EJ, Schuurman AR, Reijnders TDY, Saris A, Jongerius I, Blok SG, de Vries H, Duitman J, Vonk Noordegraaf A, Meijboom LJ, Lutter R, Heunks L, Bogaard HJ, van der Poll T. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients. Front Immunol 2021;12:664209. [PMID: 34054832 DOI: 10.3389/fimmu.2021.664209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
186 Zarkoob H, Allué-Guardia A, Chen YC, Jung O, Garcia-Vilanova A, Song MJ, Park JG, Oladunni F, Miller J, Tung YT, Kosik I, Schultz D, Yewdell J, Torrelles JB, Martinez-Sobrido L, Cherry S, Ferrer M, Lee EM. Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents. bioRxiv 2021:2021. [PMID: 34013274 DOI: 10.1101/2021.05.11.443693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
187 Seery V, Raiden SC, Algieri SC, Grisolía NA, Filippo D, De Carli N, Di Lalla S, Cairoli H, Chiolo MJ, Meregalli CN, Gimenez LI, Gregorio G, Sarli M, Alcalde AL, Davenport C, Bruera MJ, Simaz N, Pérez MF, Nivela V, Bayle C, Tuccillo P, Agosta MT, Pérez H, Villa Nova S, Suárez P, Takata EM, García M, Lattner J, Rolón MJ, Coll P, Sananez I, Holgado MP, Ferrero F, Geffner J, Arruvito L; 1 in behalf of the COVID-19 Naval Pediatric Workgroup and in behalf of the COVID-19, Fernández Pediatric Residency Workgroup. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers. EBioMedicine 2021;67:103357. [PMID: 33979758 DOI: 10.1016/j.ebiom.2021.103357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
188 Yamamoto N, Yamamoto R, Ariumi Y, Mizokami M, Shimotohno K, Yoshikura H. Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West? Int J Mol Sci 2021;22:5000. [PMID: 34066804 DOI: 10.3390/ijms22095000] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
189 Zawawi A, Naser AY, Alwafi H, Minshawi F. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis. Front Immunol 2021;12:666223. [PMID: 34046036 DOI: 10.3389/fimmu.2021.666223] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
190 Li Z, Zhao H, Wang J. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Front Cardiovasc Med 2021;8:650278. [PMID: 34026868 DOI: 10.3389/fcvm.2021.650278] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
191 Shimi G, Sohrab G, Pourvali K, Ghorbani A, Balam FH, Rostami K, Zand H. Correlation of Low Levels of α-1 Antitrypsin and Elevation of Neutrophil to Lymphocyte Ratio with Higher Mortality in Severe COVID-19 Patients. Mediators Inflamm 2021;2021:5555619. [PMID: 34007243 DOI: 10.1155/2021/5555619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
192 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
193 Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021;17:315-32. [PMID: 33903743 DOI: 10.1038/s41584-021-00608-z] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 96.0] [Reference Citation Analysis]
194 Azouz NP, Klingler AM, Callahan V, Akhrymuk IV, Elez K, Raich L, Henry BM, Benoit JL, Benoit SW, Noé F, Kehn-Hall K, Rothenberg ME. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2. Pathog Immun 2021;6:55-74. [PMID: 33969249 DOI: 10.20411/pai.v6i1.408] [Cited by in Crossref: 24] [Cited by in F6Publishing: 36] [Article Influence: 24.0] [Reference Citation Analysis]
195 Mahrooz A, Muscogiuri G, Buzzetti R, Maddaloni E. The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism. Endocrine 2021;72:317-25. [PMID: 33886062 DOI: 10.1007/s12020-021-02729-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
196 Murgia N, Corsico AG, D'Amato G, Maesano CN, Tozzi A, Annesi-Maesano I. Do gene-environment interactions play a role in COVID-19 distribution? The case of Alpha-1 Antitrypsin, air pollution and COVID-19. Multidiscip Respir Med 2021;16:741. [PMID: 34012547 DOI: 10.4081/mrm.2021.741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Mortaz E, Tabarsi P, Jamaati H, Dalil Roofchayee N, Dezfuli NK, Hashemian SM, Moniri A, Marjani M, Malekmohammad M, Mansouri D, Varahram M, Folkerts G, Adcock IM. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol 2021;12:592727. [PMID: 33968010 DOI: 10.3389/fimmu.2021.592727] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 21.0] [Reference Citation Analysis]
198 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 36.0] [Reference Citation Analysis]
199 Lopez-Castaneda S, García-Larragoiti N, Cano-Mendez A, Blancas-Ayala K, Damian-Vázquez G, Perez-Medina AI, Chora-Hernández LD, Arean-Martínez C, Viveros-Sandoval ME. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029621999099. [PMID: 33835872 DOI: 10.1177/1076029621999099] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 22.0] [Reference Citation Analysis]
200 Chalmers JD, Crichton ML, Goeminne PC, Cao B, Humbert M, Shteinberg M, Antoniou KM, Ulrik CS, Parks H, Wang C, Vandendriessche T, Qu J, Stolz D, Brightling C, Welte T, Aliberti S, Simonds AK, Tonia T, Roche N. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J 2021;57:2100048. [PMID: 33692120 DOI: 10.1183/13993003.00048-2021] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 97.0] [Reference Citation Analysis]
201 Mitchinson L, Dowrick A, Buck C, Hoernke K, Martin S, Vanderslott S, Robinson H, Rankl F, Manby L, Lewis-Jackson S, Vindrola-Padros C. Missing the human connection: A rapid appraisal of healthcare workers' perceptions and experiences of providing palliative care during the COVID-19 pandemic. Palliat Med 2021;35:852-61. [PMID: 33775169 DOI: 10.1177/02692163211004228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
202 Kiani P, Scholey A, Dahl TA, McMann L, Iversen JM, Verster JC. In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2. Viruses 2021;13:558. [PMID: 33810356 DOI: 10.3390/v13040558] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
203 Nalbandian A, Sehgal K, Gupta A, Madhavan MV, Mcgroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-nigoghossian C, Liyanage-don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med 2021;27:601-15. [DOI: 10.1038/s41591-021-01283-z] [Cited by in Crossref: 1423] [Cited by in F6Publishing: 1539] [Article Influence: 1423.0] [Reference Citation Analysis]
204 Wettstein L, Weil T, Conzelmann C, Müller JA, Groß R, Hirschenberger M, Seidel A, Klute S, Zech F, Prelli Bozzo C, Preising N, Fois G, Lochbaum R, Knaff PM, Mailänder V, Ständker L, Thal DR, Schumann C, Stenger S, Kleger A, Lochnit G, Mayer B, Ruiz-Blanco YB, Hoffmann M, Sparrer KMJ, Pöhlmann S, Sanchez-Garcia E, Kirchhoff F, Frick M, Münch J. Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nat Commun 2021;12:1726. [PMID: 33741941 DOI: 10.1038/s41467-021-21972-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 50.0] [Reference Citation Analysis]
205 Carvacho I, Piesche M. RGD-binding integrins and TGF-β in SARS-CoV-2 infections - novel targets to treat COVID-19 patients? Clin Transl Immunology 2021;10:e1240. [PMID: 33747508 DOI: 10.1002/cti2.1240] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
206 Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos GN, Poulakou G, Gatselis N, Karakike E, Saridaki M, Loli G, Stefos A, Prasianaki D, Georgiadou S, Tsachouridou O, Petrakis V, Tsiakos K, Kosmidou M, Lygoura V, Dareioti M, Milionis H, Papanikolaou IC, Akinosoglou K, Myrodia DM, Gravvani A, Stamou A, Gkavogianni T, Katrini K, Marantos T, Trontzas IP, Syrigos K, Chatzis L, Chatzis S, Vechlidis N, Avgoustou C, Chalvatzis S, Kyprianou M, van der Meer JW, Eugen-Olsen J, Netea MG, Giamarellos-Bourboulis EJ. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife 2021;10:e66125. [PMID: 33682678 DOI: 10.7554/eLife.66125] [Cited by in Crossref: 74] [Cited by in F6Publishing: 81] [Article Influence: 74.0] [Reference Citation Analysis]
207 Lindner HA, Velásquez SY, Thiel M, Kirschning T. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19. Front Immunol 2021;12:602130. [PMID: 33746948 DOI: 10.3389/fimmu.2021.602130] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
208 Owen RK, Conroy SP, Taub N, Jones W, Bryden D, Pareek M, Faull C, Abrams KR, Davis D, Banerjee J. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records. Age Ageing 2021;50:307-16. [PMID: 32678866 DOI: 10.1093/ageing/afaa167] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 60.0] [Reference Citation Analysis]
209 Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C, Subramaniam KJT, Radhakrishnan A, Bhojraj S, Kuppusamy G. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 2021;7:e06350. [PMID: 33655086 DOI: 10.1016/j.heliyon.2021.e06350] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 42.0] [Reference Citation Analysis]
210 Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O'Halloran JA, Goss C, Rauseo AM, Liu Z, Sahu SK, Peritore V, Rocco M, Ricci A, Amodeo R, Aimati L, Ibrahim M, Hachem R, Kreisel D, Mudd PA, Kulkarni HS, Gelman AE. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight 2021;6:143299. [PMID: 33444289 DOI: 10.1172/jci.insight.143299] [Cited by in Crossref: 46] [Cited by in F6Publishing: 59] [Article Influence: 46.0] [Reference Citation Analysis]
211 Zawawi A, Naser AY, Alwafi H, Minsahwi F. Circulatory Cytokines and Chemokines Profile in Human Coronaviruses: A systematic review and meta-analysis.. [DOI: 10.1101/2021.02.16.21251673] [Reference Citation Analysis]
212 Hajjar LA, Costa IBSDS, Rizk SI, Biselli B, Gomes BR, Bittar CS, de Oliveira GQ, de Almeida JP, de Oliveira Bello MV, Garzillo C, Leme AC, Elena M, Val F, de Almeida Lopes M, Lacerda MVG, Ramires JAF, Kalil Filho R, Teboul JL, Landoni G. Intensive care management of patients with COVID-19: a practical approach. Ann Intensive Care 2021;11:36. [PMID: 33604873 DOI: 10.1186/s13613-021-00820-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 35.0] [Reference Citation Analysis]
213 Desai A, Caltagirone G, Sari S, Pocaterra D, Kogan M, Azzolini E, Savevski V, Martinelli-Boneschi F, Voza A, On Behalf Of The Humanitas Covid-Task Force. The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults. J Clin Med 2021;10:686. [PMID: 33578922 DOI: 10.3390/jcm10040686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
214 Menezes MCS, Pestana DVS, Gameiro GR, da Silva LFF, Baron Ė, Rouby JJ, Auler JOC Jr. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review. Crit Care 2021;25:53. [PMID: 33557908 DOI: 10.1186/s13054-020-03399-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
215 Marques CDL, Kakehasi AM, Pinheiro MM, Mota LMH, Albuquerque CP, Silva CR, Santos GPJ, Reis-Neto ET, Matos P, Devide G, Dantas A, Giorgi RD, Marinho AO, Valadares LDA, Melo AKG, Ribeiro FM, Ferreira GA, Santos FPS, Ribeiro SLE, Andrade NPB, Yazbek MA, Souza VA, Paiva ES, Azevedo VF, Freitas ABSB, Provenza JR, Toledo RA, Fontenelle S, Carneiro S, Xavier R, Pileggi GCS, Reis APMG. High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry. RMD Open 2021;7:e001461. [PMID: 33510041 DOI: 10.1136/rmdopen-2020-001461] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 25.0] [Reference Citation Analysis]
216 Lang M, Li MD, Jiang KZ, Yoon BC, Mendoza DP, Flores EJ, Rincon SP, Mehan WA Jr, Conklin J, Huang SY, Lang AL, Giao DM, Leslie-Mazwi TM, Kalpathy-Cramer J, Little BP, Buch K. Severity of Chest Imaging is Correlated with Risk of Acute Neuroimaging Findings among Patients with COVID-19. AJNR Am J Neuroradiol 2021;42:831-7. [PMID: 33541897 DOI: 10.3174/ajnr.A7032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
217 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 385] [Cited by in F6Publishing: 443] [Article Influence: 385.0] [Reference Citation Analysis]
218 Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, Millar T, Lerpiniere CEB, Tagliavini G, Hartley CS, Randle NP, Gachanja NN, Potey PMD, Dong X, Anderson AM, Campbell VL, Duguid AJ, Al Qsous W, BouHaidar R, Baillie JK, Dhaliwal K, Wallace WA, Bellamy COC, Prost S, Smith C, Hiscox JA, Harrison DJ, Lucas CD. Tissue-Specific Immunopathology in Fatal COVID-19. Am J Respir Crit Care Med. 2021;203:192-201. [PMID: 33217246 DOI: 10.1164/rccm.202008-3265oc] [Cited by in Crossref: 150] [Cited by in F6Publishing: 209] [Article Influence: 150.0] [Reference Citation Analysis]
219 Ma A, Zhang L, Ye X, Chen J, Yu J, Zhuang L, Weng C, Petersen F, Wang Z, Yu X. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19. Front Immunol 2021;12:626235. [PMID: 33584733 DOI: 10.3389/fimmu.2021.626235] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
220 Karhadkar TR, Pilling D, Gomer RH. Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice. PLoS One 2021;16:e0245924. [PMID: 33481950 DOI: 10.1371/journal.pone.0245924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
221 Yang C, Chapman KR, Wong A, Liu M. α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action. Lancet Respir Med 2021;9:337-9. [PMID: 33485406 DOI: 10.1016/S2213-2600(21)00018-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 32.0] [Reference Citation Analysis]
222 Inoue KI, Sagawa T, Takano H. Role of IL-6 in Severe Inflammation. Am J Respir Crit Care Med 2021;203:140-1. [PMID: 32955926 DOI: 10.1164/rccm.202007-3001LE] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 McElvaney OJ, McEvoy NL, McElvaney NG, Curley GF. Reply to Blot et al. and to Inoue et al.. Am J Respir Crit Care Med 2021;203:141-2. [PMID: 32955924 DOI: 10.1164/rccm.202008-3169LE] [Reference Citation Analysis]
224 Karwaciak I, Sałkowska A, Karaś K, Dastych J, Ratajewski M. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome. Vaccines (Basel) 2021;9:54. [PMID: 33467724 DOI: 10.3390/vaccines9010054] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 25.0] [Reference Citation Analysis]
225 Larsson SC, Burgess S, Gill D. Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia. Eur Respir J 2021;57:2003545. [PMID: 33214204 DOI: 10.1183/13993003.03545-2020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
226 Krieger J, McGuire F, Risa E, Longino A, Coppess S, Riveros T, Hebert C, Town J, Bhatraju P, Johnson N. Emergency department characteristics and associations with intensive care admission among patients with coronavirus disease 2019. J Am Coll Emerg Physicians Open 2021;2:e12350. [PMID: 33490999 DOI: 10.1002/emp2.12350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
227 Lev S, Gottesman T, Sahaf Levin G, Lederfein D, Berkov E, Diker D, Zaidman A, Nutman A, Ilan Ber T, Angel A, Kellerman L, Barash E, Navon R, Boico O, Israeli Y, Rosenberg M, Gelman A, Kalfon R, Simon E, Avni N, Hainrichson M, Zarchin O, Gottlieb TM, Oved K, Eden E, Tadmor B. Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19. PLoS One 2021;16:e0245296. [PMID: 33434221 DOI: 10.1371/journal.pone.0245296] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
228 Pum A, Ennemoser M, Adage T, Kungl AJ. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. Biomolecules 2021;11:91. [PMID: 33445810 DOI: 10.3390/biom11010091] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 44.0] [Reference Citation Analysis]
229 Voicu S, Ketfi C, Stépanian A, Chousterman BG, Mohamedi N, Siguret V, Mebazaa A, Mégarbane B, Bonnin P. Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients. Front Physiol 2020;11:608788. [PMID: 33488398 DOI: 10.3389/fphys.2020.608788] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
230 Blot M, Bourredjem A, Binquet C, Piroth L; LYMPHONIE Study Group. Is IL-6 the Right Target in COVID-19 Severe Pneumonia? Am J Respir Crit Care Med 2021;203:139-40. [PMID: 32955921 DOI: 10.1164/rccm.202007-2924LE] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
231 Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, Alvarez Gil A, Poggioli R, Ruiz P, Marttos AC, Hirani K, Bell CA, Kusack H, Rafkin L, Baidal D, Pastewski A, Gawri K, Leñero C, Mantero AMA, Metalonis SW, Wang X, Roque L, Masters B, Kenyon NS, Ginzburg E, Xu X, Tan J, Caplan AI, Glassberg MK, Alejandro R, Ricordi C. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Stem Cells Transl Med 2021;10:660-73. [PMID: 33400390 DOI: 10.1002/sctm.20-0472] [Cited by in Crossref: 135] [Cited by in F6Publishing: 155] [Article Influence: 135.0] [Reference Citation Analysis]
232 Mouktaroudi M, Giamarellos-bourboulis EJ. Complex Immune Dysregulation in COVID-19 and Implications for Treatment. Annual Update in Intensive Care and Emergency Medicine 2021 2021. [DOI: 10.1007/978-3-030-73231-8_2] [Reference Citation Analysis]
233 Asadzadeh Aghdaei H, Jamshidi N, Chaleshi V, Jamshidi N, Sadeghi A, Zali MR. Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3. Gastroenterol Hepatol Bed Bench 2021;14:295-303. [PMID: 34659656] [Reference Citation Analysis]
234 Chalmers JD. Pandemic trials: evidence-based medicine on steroids. Eur Respir J 2020;56:2004116. [PMID: 33361452 DOI: 10.1183/13993003.04116-2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
235 Chen L, Wang G, Tan J, Cao Y, Long X, Luo H, Tang Q, Jiang T, Wang W, Zhou J. Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality. Signal Transduct Target Ther 2020;5:292. [PMID: 33318472 DOI: 10.1038/s41392-020-00433-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
236 Yang C, Keshavjee S, Liu M. Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation. Front Pharmacol 2020;11:615398. [PMID: 33362565 DOI: 10.3389/fphar.2020.615398] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
237 Haque A, Pant AB. Efforts at COVID-19 Vaccine Development: Challenges and Successes. Vaccines (Basel) 2020;8:E739. [PMID: 33291245 DOI: 10.3390/vaccines8040739] [Cited by in Crossref: 54] [Cited by in F6Publishing: 66] [Article Influence: 27.0] [Reference Citation Analysis]
238 Lechowicz U, Rudzinski S, Jezela-Stanek A, Janciauskiene S, Chorostowska-Wynimko J. Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein. Int J Mol Sci 2020;21:E9187. [PMID: 33276468 DOI: 10.3390/ijms21239187] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
239 Snow TAC, Singer M, Arulkumaran N. Immunomodulators in COVID-19: Two Sides to Every Coin. Am J Respir Crit Care Med 2020;202:1460-2. [PMID: 32926809 DOI: 10.1164/rccm.202008-3148LE] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
240 McElvaney OJ, O'Connor E, McEvoy NL, Fraughan DD, Clarke J, McElvaney OF, Gunaratnam C, O'Rourke J, Curley GF, McElvaney NG. Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19. J Cyst Fibros 2021;20:31-5. [PMID: 33288475 DOI: 10.1016/j.jcf.2020.11.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
241 Pandolfi L, Fossali T, Frangipane V, Bozzini S, Morosini M, D'Amato M, Lettieri S, Urtis M, Di Toro A, Saracino L, Percivalle E, Tomaselli S, Cavagna L, Cova E, Mojoli F, Bergomi P, Ottolina D, Lilleri D, Corsico AG, Arbustini E, Colombo R, Meloni F. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome. BMC Pulm Med 2020;20:301. [PMID: 33198751 DOI: 10.1186/s12890-020-01343-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 26.0] [Reference Citation Analysis]
242 Shono A, Kotani T. X. Critical Care Management of Patients with COVID-19 Pneumonia. J Jpn Soc Intern Med 2020;109:2307-2310. [DOI: 10.2169/naika.109.2307] [Reference Citation Analysis]
243 Pandolfi L, Bozzini S, Frangipane V, Percivalle E, De Luigi A, Violatto MB, Lopez G, Gabanti E, Carsana L, D’amato M, Morosini M, De Amici M, Nebuloni M, Fossali T, Colombo R, Saracino L, Codullo V, Gnecchi M, Bigini P, Baldanti F, Lilleri D, Meloni F. Neutrophil extracellular traps induce the epithelial-mesenchymal transition: implications in post-COVID-19 fibrosis.. [DOI: 10.1101/2020.11.09.374769] [Reference Citation Analysis]
244 Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020;12:E3361. [PMID: 33142828 DOI: 10.3390/nu12113361] [Cited by in Crossref: 112] [Cited by in F6Publishing: 120] [Article Influence: 56.0] [Reference Citation Analysis]
245 Liu PJ, Balfe P, McKeating JA, Schilling M. Oxygen Sensing and Viral Replication: Implications for Tropism and Pathogenesis. Viruses 2020;12:E1213. [PMID: 33113858 DOI: 10.3390/v12111213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
246 Martini F, De Mattei M, Contini C, Tognon MG. Potential Use of Alpha-1 Anti-trypsin in the Covid-19 Treatment. Front Cell Dev Biol 2020;8:577528. [PMID: 33195215 DOI: 10.3389/fcell.2020.577528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
247 Rello J, Belliato M, Dimopoulos MA, Giamarellos-Bourboulis EJ, Jaksic V, Martin-Loeches I, Mporas I, Pelosi P, Poulakou G, Pournaras S, Tamae-Kakazu M, Timsit JF, Waterer G, Tejada S, Dimopoulos G. Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium. Anaesth Crit Care Pain Med 2020;39:723-30. [PMID: 33172592 DOI: 10.1016/j.accpm.2020.10.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
248 McElvaney OJ, Hobbs BD, Qiao D, McElvaney OF, Moll M, McEvoy NL, Clarke J, O'Connor E, Walsh S, Cho MH, Curley GF, McElvaney NG. A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine 2020;61:103026. [PMID: 33039714 DOI: 10.1016/j.ebiom.2020.103026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 27.5] [Reference Citation Analysis]
249 Azouz NP, Klingler AM, Callahan V, Akhrymuk IV, Elez K, Raich L, Henry BM, Benoit JL, Benoit SW, Noé F, Kehn-Hall K, Rothenberg ME. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2. bioRxiv 2020:2020. [PMID: 33052338 DOI: 10.1101/2020.05.04.077826] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
250 Costa LHA, Santos BM, Branco LGS. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? Eur J Pharmacol 2020;889:173629. [PMID: 33022271 DOI: 10.1016/j.ejphar.2020.173629] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
251 Hellman U, Karlsson MG, Engström-Laurent A, Cajander S, Dorofte L, Ahlm C, Laurent C, Blomberg A. Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? J Biol Chem 2020;295:15418-22. [PMID: 32978255 DOI: 10.1074/jbc.AC120.015967] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 21.5] [Reference Citation Analysis]
252 Shapira G, Shomron N, Gurwitz D. Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates. FASEB J 2020;34:14160-5. [PMID: 32960480 DOI: 10.1096/fj.202002097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
253 Chalmers JD, Chotirmall SH. Rewiring the Immune Response in COVID-19. Am J Respir Crit Care Med 2020;202:784-6. [PMID: 32755507 DOI: 10.1164/rccm.202007-2934ED] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
254 Larsson SC, Burgess S, Gill D. Genetically proxied inhibition of interleukin-6 signaling: opposing associations with susceptibility to COVID-19 and pneumonia.. [DOI: 10.1101/2020.09.15.20165886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
255 Yang SC, Tsai YF, Pan YL, Hwang TL. Understanding the role of neutrophils in acute respiratory distress syndrome. Biomed J 2020:S2319-4170(20)30149-9. [PMID: 33087299 DOI: 10.1016/j.bj.2020.09.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
256 Shapira G, Shomron N, Gurwitz D. Ethnic differences in SERPINA1 allele frequencies may partially explain national differences in COVID-19 fatality rates.. [DOI: 10.1101/2020.08.24.20179226] [Reference Citation Analysis]
257 Farré N, Mojón D, Llagostera M, Belarte-Tornero LC, Calvo-Fernández A, Vallés E, Negrete A, García-Guimaraes M, Bartolomé Y, Fernández C, García-Duran AB, Marrugat J, Vaquerizo B. Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis. J Clin Med 2020;9:E2712. [PMID: 32839385 DOI: 10.3390/jcm9092712] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
258 Oguntuyo KY, Stevens CS, Siddiquey MN, Schilke RM, Woolard MD, Zhang H, Acklin JA, Ikegame S, Hung CT, Lim JK, Cross RW, Geisbert TW, Ivanov SS, Kamil JP, Lee B. In plain sight: the role of alpha-1-antitrypsin in COVID-19 pathogenesis and therapeutics. bioRxiv 2020:2020. [PMID: 32817940 DOI: 10.1101/2020.08.14.248880] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]